
ID Physician @UNMC - focus on Transplant Infectious Diseases; ID Clinical Researcher; amateur ballroom dancer
Joined February 2016
- Tweets374
- Following87
- Followers533
- Likes1.3K
Diana Florescu retweeted
Jana Broadhurst, MD, PhD, DTM&H, @UNMC_PathMicro Assistant Prof and Director of the Nebraska Biocontainment Unit Clinical Laboratory and the Emerging Pathogens Laboratory has been named one of @unmc New Investigators for 2021.
bit.ly/3FyB4aE
Diana Florescu retweeted
Huge congrats and kudos to our very own @DrAndreKalil who is the 2021 @Unmc Scientist Laureate! The award is the highest honor UNMC bestows upon its researchers. We are proud of you and all the work you have done to advance science during the pandemic! 👏
unmc.edu/news.cfm?match=2834…
The Hospital Best-Prepared for COVID-19 Is Nearly Overwhelmed - The Atlantic theatlantic.com/health/archi…
Diana Florescu retweeted
Fellowship application season is open and the leaders of our ID fellowship, Drs. Van Schooneveld & Zimmer wanted to highlight some of the exciting aspects of our program.
Check us out! bit.ly/2XVw50F
Diana Florescu retweeted
UNMC’s Dr. Mark Rupp says he is “disappointed” that the community can not put a mask mandate in place. #omaha #InThisTogether @nedhhs @omaha_scanner @OmahaPolice @DCTreasurer @DCSheriffNE @DouglasCountyNE
Diana Florescu retweeted
We are so honored to be on this prestigious list again – the only adult hospital in the state with nationally ranked specialties. Thanks again for trusting us with your care! bit.ly/33kdEGq
Diana Florescu retweeted
If you like this shirt I'm wearing and want to support a great cause toward #BlackLivesMatter then comment below and i'll reach out to you regarding purchasing one of these limited edition t shirts as featured on @KETV @OWHnews and more!
Diana Florescu retweeted
Proud of @UNMC_ID Fellow @LRearigh publishing her work on safe de-escalation of abx for FN in HCT patients. Early deescalation group actually had more of the high risk HCT groups - allos + AML/ALLs. #TxID #IDtwitter #febrileneutropenia
Our retrospective review of broad spectrum abx de-escalation in FN in HSCT is online! 🛑 broad abx after afebrile x 48hrs
❌ no increase mortality
❌ no increase ICU transfer
❌ no increase new infections
⬇️ total duration of abx
link.springer.com/article/10… @EStohs @UNMC_ID
Diana Florescu retweeted
It took the world about 100 days to go from 0 cases to 1 million detected cases. Then:
1 to 2 mil: 12 days
2 to 3 mil: 13 days
3 to 4 mil: 12 days
4 to 5 mil: 11 days
5 to 6 mil: 10 days
6 to 7 mil: 8 days
7 to 8 mil: 8 days
8 to 9 mil: 6 days
The pandemic is accelerating.
University of Nebraska among world's top 100 in earning U.S. patents | UNMC unmc.edu/news.cfm?match=2581…
Diana Florescu retweeted
Our paper describing a cytokine signature of COVID19 disease severity is now online. here we describe how we developed a rapid test to profile 4 cytokines in 1,484 COVID patients one the day of hospitalization and followed them for 49 days. 1/2 medrxiv.org/content/10.1101/…
Diana Florescu retweeted
#Remdesivir 5 vs. 10 day treatment trial for #severe #COVID19 is out!
- 5 days enough for most patients (shorter is good)
- Outcome strongly influenced by severity of disease within stratum (earlier is better)
- Outcomes comparable to #ACTT1 overall
link:nejm.org/doi/full/10.1056/NE…
Diana Florescu retweeted
WHO Halts Hydroxychloroquine Trial Over Safety Concerns npr.org/sections/coronavirus…
Diana Florescu retweeted
Dr. Rupp sharing some useful information with @CNN earlier today, explaining the importance of wearing a mask. #WearAMask
Dr. Mark Rupp of @unmc reacts to a study saying Covid-19 may remain in the air for 8 minutes after talkling.
It "emphasizes the importance of why we should all be wearing masks...It's really no surprise that when somebody's talking, they're going to be generating these droplets."
Diana Florescu retweeted
NEW Correspondence—Retinal findings in patients with #COVID19
Paula M Marinho et al report retinal and optical coherence tomography changes in 12 adults (six men and six women, aged 25–69 years), examined 11–33 days after COVID-19 symptom onset hubs.ly/H0qsT-g0




























